Paper39350367
Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force.
Angioni D and 17 others. J Prev Alzheimers Dis, 2024. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force. Papers, record 39350367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39350367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Humans | |
| Clinical Trials as Topic | |
| Advisory Committees |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P20 GM109025 | NIGMS NIH HHS | United States | P20GM109025 | PubMed and NIH | NIH RePORTER |
| R01 AG053798 | NIA NIH HHS | United States | R01AG053798 | PubMed and NIH | NIH RePORTER |
| R25 AG083721 | NIA NIH HHS | United States | R25AG083721 | PubMed and NIH | NIH RePORTER |
| R35 AG071476 | NIA NIH HHS | United States | R35AG071476 | PubMed and NIH | NIH RePORTER |
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30830492 | An overview of using qualitative techniques to explore and define estimates of clinically important change on clinical outcome assessments. | J Patient Rep Outcomes | 2019 | https://conductscience.org/library/papers/30830492 | PubMed |
| 2 | 28341540 | Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors. | Alzheimers Dement | 2017 | https://conductscience.org/library/papers/28341540 | PubMed |
| 3 | 36856953 | Lecanemab: First Approval. | Drugs | 2023 | https://conductscience.org/library/papers/36856953 | PubMed |
| 4 | 36094645 | Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial. | JAMA Neurol | 2022 | https://conductscience.org/library/papers/36094645 | PubMed |
| 5 | 35542991 | Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease. | J Prev Alzheimers Dis | 2022 | https://conductscience.org/library/papers/35542991 | PubMed |
| 6 | 38111596 | Using a digital tool to detect early changes in everyday functioning in older adults: A pilot study of the Assessment of Smartphone Everyday Tasks (ASSET). | Alzheimers Dement (Amst) | 2023 | https://conductscience.org/library/papers/38111596 | PubMed |
| 7 | 36891463 | Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings. | Neurol Clin Pract | 2023 | https://conductscience.org/library/papers/36891463 | PubMed |
| 8 | 38480971 | Researchers call for a major rethink of how Alzheimer's treatments are evaluated. | Nature | 2024 | https://conductscience.org/library/papers/38480971 | PubMed |
| 9 | 39015065 | Care partner-informed meaningful change thresholds for the Clinical Dementia Rating-Sum of Boxes for trials of early Alzheimer's disease. | Alzheimers Dement | 2024 | https://conductscience.org/library/papers/39015065 | PubMed |
| 10 | 8232972 | The Clinical Dementia Rating (CDR): current version and scoring rules. | Neurology | 1993 | https://conductscience.org/library/papers/8232972 | PubMed |
| 11 | 37388759 | Donanemab exposure and efficacy relationship using modeling in Alzheimer's disease. | Alzheimers Dement (N Y) | 2023 | https://conductscience.org/library/papers/37388759 | PubMed |
| 12 | 32369109 | Patient-Reported Outcome Measures to Inform Care of People With Dementia-A Systematic Scoping Review. | Gerontologist | 2021 | https://conductscience.org/library/papers/32369109 | PubMed |
| 13 | 12740036 | Quality of Life measures for dementia. | Health Qual Life Outcomes | 2003 | https://conductscience.org/library/papers/12740036 | PubMed |
| 14 | 35676941 | Integrated Alzheimer's Disease Rating Scale: Clinically meaningful change estimates. | Alzheimers Dement (N Y) | 2022 | https://conductscience.org/library/papers/35676941 | PubMed |
| 15 | 37357301 | 'Time Saved' As a Demonstration of Clinical Meaningfulness and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings. | J Prev Alzheimers Dis | 2023 | https://conductscience.org/library/papers/37357301 | PubMed |
| 16 | 7999340 | Quality of life in Alzheimer disease. | Alzheimer Dis Assoc Disord | 1994 | https://conductscience.org/library/papers/7999340 | PubMed |
| 17 | 15592144 | The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database. | Alzheimer Dis Assoc Disord | 2004 | https://conductscience.org/library/papers/15592144 | PubMed |
| 18 | 36656587 | Patient-Reported Outcome Measures in Oncology Drugs Approved by the European Medicines Agency, 2017-2021. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/36656587 | PubMed |
| 19 | 35694928 | Demonstration of Clinical Meaningfulness of the Integrated Alzheimer's Disease Rating Scale (iADRS): Association Between Change in iADRS Scores and Patient and Caregiver Health Outcomes. | J Alzheimers Dis | 2022 | https://conductscience.org/library/papers/35694928 | PubMed |
| 20 | 28624901 | Idio Scale Judgment: evaluation of a new method for estimating responder thresholds. | Qual Life Res | 2017 | https://conductscience.org/library/papers/28624901 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42963333 | Expert perspectives on the design and communication of endpoints in Alzheimer's disease clinical trials. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42963333 | PubMed |
| 42625495 | Beyond the Cochrane review: Re-evaluating anti-amyloid therapy in Alzheimer's disease. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42625495 | PubMed |
| 41724687 | Clinical meaningfulness of anti-amyloid therapies in early Alzheimer's disease: Perspectives from the East and Southeast Asia region. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/41724687 | PubMed |
| 41708398 | Systemic inflammation, delirium and clinical progression in mild-moderate Alzheimer disease. | EBioMedicine | 2026 | https://conductscience.org/library/papers/41708398 | PubMed |
| 41640999 | Predicting progression from amnestic mild cognitive impairment to Alzheimer's disease using longitudinal EEG data: a 12-month cohort study. | Front Aging Neurosci | 2025 | https://conductscience.org/library/papers/41640999 | PubMed |
| 41470118 | Associations Between Cognitive Performance and Motor Signs in Older Adults with Alzheimer's Dementia. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/41470118 | PubMed |
| 41287474 | Linking traditional and technological activities of daily living: Building modern, adaptable measures of daily functioning. | J Int Neuropsychol Soc | 2025 | https://conductscience.org/library/papers/41287474 | PubMed |
| 40765720 | Utilizing MCID for evaluating clinical relevance of AD therapeutic interventions. | Alzheimers Dement (N Y) | 2025 | https://conductscience.org/library/papers/40765720 | PubMed |
| 40413790 | Enhancing Interpretation of Cognitive Changes in Alzheimer's Intervention Trials: Application of Standardized Regression-Based Change Scores. | Arch Clin Neuropsychol | 2025 | https://conductscience.org/library/papers/40413790 | PubMed |
| 40253240 | Challenges and opportunities for novel combination therapies in Alzheimer's disease: a report from the EU/US CTAD Task Force. | J Prev Alzheimers Dis | 2025 | https://conductscience.org/library/papers/40253240 | PubMed |
| 40225240 | Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression? | Alzheimers Dement (N Y) | 2025 | https://conductscience.org/library/papers/40225240 | PubMed |
| 40111937 | Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting. | J Alzheimers Dis | 2025 | https://conductscience.org/library/papers/40111937 | PubMed |
| 40076979 | Differential Transcriptional Programs Reveal Modular Network Rearrangements Associated with Late-Onset Alzheimer's Disease. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076979 | PubMed |
| 40051090 | Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective. | Br J Clin Pharmacol | 2025 | https://conductscience.org/library/papers/40051090 | PubMed |
| 39974177 | The elusive relationship between retinal anatomy and brain amyloid. | Brain Commun | 2025 | https://conductscience.org/library/papers/39974177 | PubMed |
| 39748838 | Alzheimer's disease drug development in an evolving therapeutic landscape. | Alzheimers Dement (N Y) | 2024 | https://conductscience.org/library/papers/39748838 | PubMed |
| 39692602 | Appropriate use of meaningful within-patient change (MWPC) thresholds in Alzheimer's disease. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/39692602 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39350367
GET https://conductscience.org/api/papers/v1/39350367/references?page=2